Clinical Trial/MUHS/ ICMR/Any Other

Sr. No Title of research project Name of Principle investigator Sanctioning/ Collaborating agency Completed/Ongoing
1 Clinical trial-  A randomized, open label, two  way crossover study to compare inhalation flow profiles  generated with medication free generic tiotropium bromide inhalation  device of Cipla Ltd, India and SPIRIVA HANDIHALER device of Boehringer ingelheim pharmaceuticals, inc, USA in healthy adult subjects and adult subjects with moderate, sever and very severe chronic obstructive pulmonary disease (Crd/27)(the clinical study) Dr. Gauri Kulkarni Cipla  ltd Ongoing
2 Prospective, open label, multicentre, single arm, post  marketing study for evaluation of safety and efficacy of  Favipiravir in adult Indian patients with mild to moderate  covid-19 disease Dr Ravindra Shinde Glenmark ltd Ongoing
  • Research activity of Department:
Sr. No. Year Title of the Research Name Status
1 2019 Outcome of multidrug Resistant Tuberculosis 5yr follow up study Dr. Gauri Kulkarni

Dr. Nilesh Patil

 

Completed
2 2019 To Study Respiratory Manifestation in chronic Renal Failure Patients Dr. G. S. Kulkarni

Dr. Nikhil Raj

 

Completed
3 2019 Study of Clinical Profile H1 N1 Swine flu influenza patients at a tertiary care center Dr. R. M. Sundrani

Dr. G. S. Kulkarni

Dr. Jaspreet Singh

 

Completed
4 2019 Study of Adverse Drug reactions Related to Pre XDR and XDR Tuberculosis on Bedaquline Drug within 14 days of Admission Dr. S. R. Dugad

 

Completed
5 2020 Clinical Characteristics of Covid 19 (Sars-Cov-2) Patients at a Tertiary Health Care Centre Dr. Ravindra Shinde

Dr. Chaitanya Kappagantu

Ongoing
6 2020 Clinicoradiological Corelation In Covid 19 (Sars-Cov-2) Patients Admitted at Aa Tertiary  Health Care Centre” Dr. Ravindra Shinde , Dr. Jaspreet

 

Ongoing
7 2020 Clinical characteristics of asymptomatic patients of COVID 19 patients admitted in tertiary health care centre Dr. Sushama Dugad, Dr. Siddhesh Bharadi ongoing
8 2021 “Outcome of clinico radiological and sputum culture conversion of drug Resistant tuberculosis patient receiving bedaquiline regimen at end of 6 months At nodal drug resistance tuberculosis centre, Nashik” Dr. Chaitanya Kappagantu

Dr Sushama R Dugad

Ongoing
9 2021 Study of outcome of extra pulmonary drug resistant tuberculosis patient at nodal drug resistance tuberculosis center, Nashik Dr. Chaitanya Kappagantu

Dr Ravindra Shinde

Ongoing
10 2021 Prospective, open label, multicentre, single arm, post  marketing study for evaluation of safety and efficacy of  Favipiravir in adult Indian patients with mild to moderate  covid-19 disease Dr Ravindra Shinde Ongoing